The MAGNOLIA study is open to male and female patients with pathologically confirmed muscle invasive transitional cell carcinoma of the urinary bladder with expression of the antigen MAGE-A3 with or without limited lymph node involvement who have no evidence of disease after surgery confirmed with imaging procedures (scans CT/MRI).